Form 4 for RARE Ultragenyx Pharmaceutical Inc.
Accepted 2021-09-09 00:00:00 ET · period of report 2021-09-08 · accession 0001209191-21-055362 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-09 | 2021-09-08 | RARE | Parschauer Karah Herdman | EVP, GC | S - Sale+OE | $100.65 | -7,336 | 28.7K | -20% | -$738.4K |
| D | 2021-09-09 | 2021-09-08 | RARE | Parschauer Karah Herdman | EVP, GC | M - OptEx | $54.50 | +7,336 | 36.0K | +26% | +$399.8K |
| D | 2021-09-09 | 2021-09-08 | RARE | Parschauer Karah Herdman | EVP, GC | M - OptEx | $0.00 | -7,336 | 17.7K | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-08 | S | D | 7,336 | $100.65 | 28,668 | D | — | — | (F1) Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. |
| 2 | Common | Common Stock | 2021-09-08 | M | A | 7,336 | $54.50 | 36,004 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-09-08 | M | D | 7,336 | $0.00 | 17,664 | D | $54.50 · — to 2026-06-20 | 7,336 Common Stock | (F2) The option vested with respect to 1/4th of the shares on June 20, 2017 (the first anniversary of the grant date of the option or the "Option Anniversary Date") and 1/48th of the shares initially subject to the option continued to vest on each month as measured from the Option Anniversary Date such that the option fully vested on the fourth anniversary of the grant date. |